GITNUX MARKETDATA REPORT 2024
Cervical Cancer Industry Statistics
Cervical cancer remains a significant global health issue, with approximately 570,000 new cases and 310,000 deaths reported each year, disproportionately affecting low- and middle-income countries.
In this post, we will examine critical statistics surrounding the cervical cancer industry, shedding light on the global prevalence, mortality rates, research and development expenditures, clinical trials, and market trends. Stay tuned to gain valuable insights into the landscape of cervical cancer, including the challenges faced in prevention, screening, and treatment across various regions.
Statistic 1
"Cervical cancer is the fourth most common cancer in women worldwide."
Statistic 2
"In 2020, an estimated 604,000 women were diagnosed with cervical cancer worldwide."
Statistic 3
"Cervical cancer caused about 342,000 deaths globally in 2020."
Statistic 4
"In 2018, nearly 90% of cervical cancer deaths occurred in low- and middle-income countries."
Statistic 5
"Human papillomavirus (HPV) types 16 and 18 cause around 70% of cervical cancers and pre-cancerous cervical lesions."
Statistic 6
"Clinical trial spending for cervical cancer treatments exceeded USD 300 million in the United States in 2020."
Statistic 7
"There were approximately 1,500 clinical trials focusing on cervical cancer worldwide in 2019."
Statistic 8
"Sales of cervical cancer drugs exceeded USD 1.3 billion in the United States in 2018."
Statistic 9
"Approximately 84% of cervical cancers are found in the developing world, where there are fewer resources for prevention, screening, and treatment."
Statistic 10
"The five-year survival rate for cervical cancer when detected at an early stage is approximately 92%."
Statistic 11
"The global HPV testing & Pap test market generated revenue of approximately USD 3.2 billion in 2015."
Statistic 12
"Between 2020 and 2030, the market for cervical cancer therapeutics is expected to expand at a CAGR of approximately 6%."
Statistic 13
"Research and development expenditure of cervical cancer drugs in the U.S alone surpassed USD 100 million in 2020."
Statistic 14
"In 80% of cases, cervical cancer is found in women over the age of 50."
Statistic 15
"The cervical cancer treatment market in Europe is anticipated to witness significant growth owing to the presence of a well-established healthcare infrastructure."
Statistic 16
"The cervical cancer therapeutics market in Latin America is anticipated to expand at a CAGR of 6%, driven by the increasing incidence of the disease."
Statistic 17
"Cervical cancer is the second most common cancer among women aged 15 to 44 in the Middle East and Africa region."
Jannik Lindner
Can You Trust Our Report?
The statistics are checked by us and then entered into the database. Our market data reports have been linked to by some of the largest publishers and companies on the Internet.
